Curevo Vaccine
A clinical-stage biotech company developing amezosvatein, a vaccine for shingles and chickenpox.
44 employees · est. 2017 · Bothell, United States
TechnoVax, Inc. is the older company (2017 vs 2003); Curevo Vaccine is the larger of the two.
Side-by-Side Comparison
| Metric | Curevo Vaccine | TechnoVax, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2003 older |
| Headquarters | ||
| Headquarters | Bothell, United States | United States |
| Employees | ||
| Employees | 44 larger | 5 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Health Care |
| Funding Stage | ||
| Funding Stage | Acquired | Equity Crowdfunding |
| Total Funding | ||
| Total Funding | $196.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Development of next-generation non-mRNA vaccines, Clinical trials for vaccine efficacy and safety, Comparative studies with existing vaccines, Improving tolerability and accessibility of vaccines | Not tracked yet |
| Target Customers | ||
| Target Customers | Individuals susceptible to shingles and chickenpox, Immunocompromised patients, particularly children, Healthcare providers and institutions, Global health organizations and vaccine distributors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biotech, Vaccine Development, Clinical-Stage Biotech, Amezosvatein, Herpes Zoster Vaccine, Chickenpox Vaccine, Shingles Vaccine, Varicella Zoster Virus, Adjuvanted Subunit Vaccine, Immunology, Drug Development, Reactogenicity Improvement, Public Health, Infectious Disease, Clinical Trials | Vaccine Development, Virus-Like Particles, Respiratory Diseases, Hemorrhagic Fevers, Immunodeficiency, Cancer Vaccines, Universal Flu Vaccine, Inhaled Powder Flu Vaccine, RSV Vaccine, Strategic Partnerships, Funding, Clinical-stage Biotechnology, Tarrytown, NY, Non-dilutive Funding |
| Website | ||
| Website | curevovaccine.com | technovax.com |
About Curevo Vaccine
Curevo Vaccine, founded in 2017, is a clinical-stage biotech company based in the United States. Specializing in the development of vaccines for varicella and herpes zoster, the company is advancing its flagship product, Amezosvatein (CRV-101), a non-mRNA, adjuvanted subunit vaccine aimed at prevent...
About TechnoVax, Inc.
TechnoVax, Inc. is a Tarrytown, NY-based biotechnology company founded in 2003. Specializing in viral vaccine development, the company's mission is to create and advance safe, unique, and novel vaccine technologies with no current alternatives, revolutionizing the way vaccines are developed and admi...
We will tell you when either one moves
BounceWatch watches Curevo Vaccine and TechnoVax, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Curevo Vaccine and TechnoVax, Inc. — by email.
Frequently Asked Questions
Compare Curevo Vaccine with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Curevo Vaccine on 11 Mar 2026, and TechnoVax, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.